Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Remarkably, 1,25-dihydroxyvitamin D₃ (1,25(OH)₂D₃) pretreatment significantly downregulated TREM2 on macrophages (by flow cytometry) (Supplementary Fig. 20A, B).

Source: Is vitamin D treatment associated with reduced TREM2 expression, fewer lipid droplets, and lower Mtb viability?. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Mixed research settings

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Patients were enrolled at the time of diagnosis, before initiating therapy.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia

Study design awaiting verification · Nature Communications · 2026

Original publication title

Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia

Rosane M. B. Teles; Chaouki Benabdessalem; Jonathan Perrie; Cenfu Wei; Julie West; Bruno J. de Andrade Silva; Priscila R. Andrade; Lilah A. Mansky; Prajan Divaka; Linda Fischbacher; Karen Lam; Feiyang Ma; Yiqian Gu; Kimia Rategh; Madeline Brown; Aparna Pillai; Kapongo Lumamba; Threnesan Naidoo; Samuel M. French; Emna Romdhane; Mohamed-Ridha Barbouche; Eynav Klechevsky; Marco Colonna; Adrie J. C. Steyn; Steven J. Bensinger; Daniel L. Barber; Soumaya Rammeh; Parambir S. Dulai; Bryan D. Bryson; Matteo Pellegrini; John T. Belisle; Barry R. Bloom; Robert L. Modlin

© The Author(s) 2026

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Pulmonary tuberculosis (TB), caused by lung infection with Mycobacterium tuberculosis (Mtb), often manifests both alveolar pneumonia and aggregation of immune cells containing Mtb, termed granulomas, within the same lung. Here, we integrate spatial transcriptomics, single-cell RNA sequencing, high-resolution imaging, and functional assays of lung biopsies from four men with pulmonary TB to compare alveolar pneumonia with adjacent granulomas. We find that alveolar TB pneumonia is enriched for TREM2⁺ lipid-laden macrophages characterized by increased lipid metabolism gene expression, reduced T cell infiltration, attenuated antimicrobial gene expression, and abundant Mtb transcripts and antigens.

By contrast, neighboring granulomas exhibit organized lymphoid architecture and robust antimicrobial programs. In vitro, Mtb lipids induce TREM2 expression, activate TREM2: DAP12 signaling, and promote lipid droplet accumulation in primary human monocyte-derived macrophages (MDM). Furthermore, TREM2+ MDMs are more susceptible to in vitro Mtb infection. When treating MDMs with 1,25-dihydroxyvitamin D₃, which induces antimicrobial macrophage programs, TREM2+ MDM numbers, lipid droplet abundance and Mtb viability are decreased. Thus, we propose a spatially localized, alveolar pneumonia-intrinsic TREM2⁺ macrophage program that potentially contributes to Mtb persistence in pulmonary TB infection in humans.

Pulmonary tuberculosis infection of the lung induces alveolar pneumonia and granulomas. Here, the authors analyze lung biopsies from four men with pulmonary tuberculosis, finding alveolar pneumonia to be enriched for TREM2+ macrophages, which are more susceptible for Mycobacterium tuberculosis infection than TREM2: macrophages.

Authors’ abstract

Pulmonary tuberculosis (TB), caused by lung infection with Mycobacterium tuberculosis (Mtb), often manifests both alveolar pneumonia and aggregation of immune cells containing Mtb, termed granulomas, within the same lung. Here, we integrate spatial transcriptomics, single-cell RNA sequencing, high-resolution imaging, and functional assays of lung biopsies from four men with pulmonary TB to compare alveolar pneumonia with adjacent granulomas. We find that alveolar TB pneumonia is enriched for TREM2⁺ lipid-laden macrophages characterized by increased lipid metabolism gene expression, reduced T cell infiltration, attenuated antimicrobial gene expression, and abundant Mtb transcripts and antigens.

By contrast, neighboring granulomas exhibit organized lymphoid architecture and robust antimicrobial programs. In vitro, Mtb lipids induce TREM2 expression, activate TREM2: DAP12 signaling, and promote lipid droplet accumulation in primary human monocyte-derived macrophages (MDM). Furthermore, TREM2+ MDMs are more susceptible to in vitro Mtb infection. When treating MDMs with 1,25-dihydroxyvitamin D₃, which induces antimicrobial macrophage programs, TREM2+ MDM numbers, lipid droplet abundance and Mtb viability are decreased. Thus, we propose a spatially localized, alveolar pneumonia-intrinsic TREM2⁺ macrophage program that potentially contributes to Mtb persistence in pulmonary TB infection in humans.

Pulmonary tuberculosis infection of the lung induces alveolar pneumonia and granulomas. Here, the authors analyze lung biopsies from four men with pulmonary tuberculosis, finding alveolar pneumonia to be enriched for TREM2+ macrophages, which are more susceptible for Mycobacterium tuberculosis infection than TREM2: macrophages.

Publication and source details

Original title: Identification of a spatially organized TREM2-associated permissive macrophage niche in human pulmonary tuberculosis alveolar pneumonia

Rosane M. B. Teles; Chaouki Benabdessalem; Jonathan Perrie; Cenfu Wei; Julie West; Bruno J. de Andrade Silva; Priscila R. Andrade; Lilah A. Mansky; Prajan Divaka; Linda Fischbacher; Karen Lam; Feiyang Ma; Yiqian Gu; Kimia Rategh; Madeline Brown; Aparna Pillai; Kapongo Lumamba; Threnesan Naidoo; Samuel M. French; Emna Romdhane; Mohamed-Ridha Barbouche; Eynav Klechevsky; Marco Colonna; Adrie J. C. Steyn; Steven J. Bensinger; Daniel L. Barber; Soumaya Rammeh; Parambir S. Dulai; Bryan D. Bryson; Matteo Pellegrini; John T. Belisle; Barry R. Bloom; Robert L. Modlin

Nature Communications · 2026

© The Author(s) 20262026https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.NIH grants R01 AI022553, R01 AR040312, R01 AI166313, R01 AI169526, P50 AR080594

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-10T21:51:12.465520+00:00

DOI: 10.1038/s41467-026-76814-8 · PMC13669344